Physician Assistant in Onancock, VA Accepting Medicare
4 Physician Assistant nurses found. Showing 1 - 4
 Thomas Fisher Hare, RPA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 20486 Market Street, Onancock, VA 23417 Phone: 757-302-2700 Fax: 757-787-9262 |
Paul Morgan Stevenson, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 20280 Market St, Onancock, VA 23417 Phone: 757-695-5503 |
 Michelle Jugovich, Physician Assistant Medicare: Medicare Enrolled Practice Location: 20280 Market St, Onancock, VA 23417 Phone: 757-414-0400 |
Sierra Dickman Cuppett, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 20306 Badger Ln, Onancock, VA 23417 Phone: 757-787-7374 |
News Archive
Study of internet-delivered trauma-focused CBT shows promising results
Traumatic experiences such as assault or a road accident can give rise to nightmares, flashbacks and other mental reactions, and accessible therapy is needed to prevent exacerbation of the problems.
PGT Innovations joins hands with All-Star Children's Foundation to help kids victimized by abuse
PGT Innovations is partnering with the All-Star Children's Foundation, during the Community Foundation of Sarasota County's Giving Challenge on May 1 - 2 from noon to noon, to help fund a new 5-acre, state-of-the-art campus that provides trauma-informed care for children of abuse.
New assessment shows continued serious fuel and water shortages at Lebanese health facilities
A newly-published assessment of health facilities in Lebanon shows that a quarter of those examined are not functioning due to physical damage, lack of staff or lack of accessibility, and that water and fuel shortages remain a serious concern.
Abcodia raises £5.25 million funding to launch ovarian cancer screening test, ROCA
Abcodia today announced that it has raised £5.25 million funding from existing and new investors to bring the world's most sensitive and specific ovarian cancer screening test, ROCA to market.
Investing in new hepatitis C therapies may have significant economic impact
While a new generation of safer, more effective oral medications to treat hepatitis C patients may cost tens of thousands of dollars for a 12-week regiment, investing in these new therapies could generate savings estimated at more than $3.2 billion annually in the U.S. and five European countries, according to a new study (abstract 228) released today at Digestive Disease Week® (DDW) 2015.
› Verified 7 days ago